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Uncoupling proteins (UCPs) are specialized members of the mitochondrial transporter family. They allow passive proton transport through the
mitochondrial inner membrane. This activity leads to uncoupling of mitochondrial respiration and to energy waste, which is well documented with
UCP1 in brown adipose tissue. The uncoupling activity of the new UCPs (discovered after 1997), such as UCP2 and UCP3 in mammals or avUCP
in birds, is more difficult to characterize. However, extensive data support the idea that the new UCPs are involved in the control of reactive
oxygen species (ROS) generation. This fits with the hypothesis that mild uncoupling caused by the UCPs prevents ROS production. Activators
and inhibitors regulate the proton transport activity of the UCPs. In the absence of activators of proton transport, the UCP allows the permeation of
other ions. We suggest that this activity has physiological significance and, for example, UCP3 expressed in glycolytic muscle fibres may be a
passive pyruvate transporter ensuring equilibrium between glycolysis and oxidative phosphorylation. Induction of UCP2 expression by glutamine
strengthens the proposal that new UCPs could act to determine the choice of mitochondrial substrate. This would obviously have an impact on
mitochondrial bioenergetics and ROS production.
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This article covers the topics presented by one of us (FB) at
the Bari Meeting (17–22 December 2005). Most of the results
discussed here are published [1,2] or in manuscripts that are in
revision [3] or preparation [4]. They are enriched by further
speculations and comments following questions raised during
this meeting. Some previously unpublished results are also
presented.
For reviews on uncoupling proteins (UCPs) see [5–11].
From 1976 to 1997, only one UCP, now called UCP1, was
known. UCP1 is expressed in the brown adipose tissue of
mammals and is necessary for the inducible thermogenic
activity of this tissue. In 1997, two genes were discovered in
mammals that code for proteins sharing about 60% sequence
similarity with UCP1. Because of this similarity, and also⁎ Corresponding author. Tel.: +33 1 40 61 56 71; fax: +33 1 40 61 56 73.
E-mail address: bouillaud@necker.fr (F. Bouillaud).
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doi:10.1016/j.bbabio.2006.06.002because the first experiments using recombinant expression
showed a modification of mitochondrial activity consistent with
uncoupling, these proteins were called UCP2 and UCP3.
Related proteins have been found in other phyla, including
plants, and in birds (called here avUCP). We will use the term
“new UCPs” to distinguish these proteins discovered after 1997
from the original UCP1. The relationships between the
respiratory chain, FoF1 ATPase, and UCP are illustrated in
Fig. 1. UCP simply allows passive proton return through the
mitochondrial inner membrane, whereas FoF1 ATPase couples
this proton return to phosphorylation of ADP into ATP.
Consequently, in the presence of UCP oxidation accelerates,
whereas ATP production by mitochondria diminishes. Other
consequences of uncoupling are also shown on the bottom of
Fig. 1. Lowering of the mitochondrial membrane potential
(ΔΨ) is the first observable event when UCP activity is
suddenly stimulated. The effect on production of reactive
oxygen species (ROS) by the respiratory chain of mitochondria
needs further explanation: in simple terms one may accept that
Fig. 1. Schematic representation of mitochondrial bioenergetics: In the absence
of UCP (top), from left to right: catabolism leads to reduction of coenzymes into
NADH or FADH2. These reduced coenzymes supply electrons to the
mitochondrial respiratory chain which links electron movement to oxygen to
form water with proton pumping. ROS are produced when electrons escape this
normal route. Only the electrical componentΔΨ of the electrochemical potential
for protons is indicated. The mitochondrial ATPase (working as an ATP synthase
here) couples proton re-entry to ATP production. While the elements shown to
the right of the respiratory chain are represented with the correct topology in the
inner mitochondrial membrane, no topological information is given on the left.
In the presence of UCP (middle): UCP offers an alternative pathway to protons
that is not linked to ATP synthesis. Gating the UCP according to the potential
and changing the UCP abundance determines how much the UCP compete with
the ATPase for protons. In the case of brown adipose tissue, UCP1 dominates
and uncoupling is complete. Bottom: expected effect on oxygen consumption
(JO2) of the uncoupling (proton transport) activity of the UCP, ATP/ADP ratio,
membrane potential (ΔΨ) and ROS production.
Fig. 2. The three functional states of the UCP1: in the absence of any ligand
(white), UCP1 is able to transport various ions including protons. Binding of
nucleotides to UCP1 inhibits this transport (black). Interaction of UCP1 with
fatty acids leads to activation of proton transport by UCP1 (grey). Similar
regulation patterns are proposed for the new UCPs (UCP2, UCP3, avUCP, plant
UCPs…).
1285F. Criscuolo et al. / Biochimica et Biophysica Acta 1757 (2006) 1284–1291ROS production by mitochondria is explained by crowding of
electrons within the respiratory chain complexes I and III [12].
To form ROS some of these electrons escape from the normal
pathway that link movement of pairs of electrons to proton
pumping. Increasing permeability of the inner membrane to
protons facilitates this normal pathway, and hence reduces the
crowding of electron and ROS production, the price being
increased waste of energy. Consequently, soon after the
discovery of UCP2 and UCP3 it was proposed that these
proteins might be involved in the control of ROS production
[13]. Experimental data now support this point of view [14,15],
whereas the relevance of UCP2 or UCP3 to the control of
energy expenditure seems doubtful. Mitochondrial ROS
formation might be of physiological relevance but is also very
likely a major source of damage, at least at the mitochondrial
level [16].
From the early studies with UCP1 it became apparent that the
activity of UCP itself is regulated [17]. This occurs via binding
of activating or inhibiting ligands to the UCP. Nucleotides (ATP,
ADP, GTP, GDP) inhibit and fatty acids activate UCP1 [18].
After discovery of new UCPs, more or less similar mechanismsof the regulation of their proton transport activity have been
proposed [19–21]. The UCP may therefore exist in three states
(Fig. 2): (1) inactive with an bound inhibitor (black), (2) proton
transport mode with an activator of proton transport linked to
the UCP (grey), (3) with no ligand (white). The latter state is
supposed to be of little significance for UCP1 since intracellular
nucleotide concentrations are expected to ensure that UCP1 is
largely inhibited. However, data obtained with isolated
mitochondria and with UCP1 reconstituted in proteoliposomes
support the fact that, in the absence of any ligands, UCPs exhibit
transport activity. This transport activity concerns anions such
as chloride but also organic anions including pyruvate [22].
Does proton transport occur too, when no activating compound
is bound to the UCP? We believe that this is the case with UCP1
[23]. This is much more doubtful with the other UCPs (UCP2,
UCP3, avUCP). In fact, a consensus has more or less been
reached considering that the new UCPs need specific activation
for the proton transport to occur [2,19–21,24]. In contrast, the
anion transport can occur without activation [25].
The purpose of this paper is to promote the idea that transport
by the UCP might be of physiological relevance even in the
absence of the ligand(s) promoting proton transport. This
hypothesis is based on several observations that led us to
consider that whereas proton conductance through UCP3 did
not take place within cells, the cell metabolism was still
influenced by the presence of UCP3. A second set of arguments
came from the observation that UCP2 expression was
stimulated by glutamine, a known substrate for mitochondrial
oxidation, pointing to the possibility that UCP2 and UCP3
function is more linked to the choice of mitochondrial substrate
than to the determination of the passive proton conductance of
the inner membrane. This effect is expected to have complex
consequences for mitochondrial metabolism, including, but not
limited to, ROS production.
At this point it should be underlined that the proposal that
UCPs influence substrate use by mitochondria is not entirely
new. It has been proposed that the new UCPs control fatty acid
metabolism in mitochondria [11,26]. The proposed explanation
Fig. 3. ROS formation in COS cells: Cells were examined by flow cytometry as
described in [1]. y axis: superoxide production measured by the increase in red
fluorescence due to oxidation of dihydroethidium by superoxide. x axis: time in
hours. The data points represent four independent experiments. Empty symbol
and dotted lines: control (COS cells). Filled symbols and solid line: the avUCP
clone. Circles: cells in basal state. Squares: cells poisoned with oligomycin, an
inhibitor of mitochondrial ATPase which therefore reduces JO2, and increases
ΔΨ and ROS formation.
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we will explain later why the distinction between this activity
and uncoupling is problematic.
2. Failure to find uncoupling
Recombinant expression in cell lines has been used to study
UCP activity. Using this system, we aimed to study the
influence of UCP expression at the cellular level. A study was
undertaken with a series of CHO cell lines expressing UCP3
and a large set of control CHO cell lines expressing no
recombinant protein or other proteins supposed to be of no
relevance to mitochondrial activity. A UCP1-expressing clone
[29] was also included. It was observed that under standard
conditions the presence of UCP3 somehow seemed to influence
mitochondrial activity [1]. Many (not all) of these initial
observations agreed with the consequences of uncoupling
presented above (Fig. 1). However, we failed each time we
attempted to manipulate experimental conditions to enhance the
influence of UCP3 within the theoretical framework of a limited
uncoupling [1]. This observation was not restricted to UCP3 (or
UCP1) in CHO cells: our early attempts with cells expressing
UCP2 led to a similar conclusion (unpublished data). Fig. 3
shows experiments with the avian UCP expressed in COS cells.
In the basal respiratory state, ROS production was lower in the
avUCP-expressing cells than in controls (Fig. 3 circles).
Addition of the ATPase inhibitor oligomycin reduced the
respiratory rate and caused hyperpolarization of mitochondria
(not shown here but see [1]), and therefore increased ROS
production. The uncoupling hypothesis would predict that
oligomycin increases the difference between the avUCP clone
and its control. In fact, in the presence of oligomycin this
difference disappeared (Fig. 3 squares). As with UCP3, attempts
to promote the relative influence of avUCP within the
framework of the uncoupling hypothesis failed. Finally, the
UCP1 clone showed that within the CHO cells the uncoupling
activity of the UCP1 is inhibited [1], which was observed before
with transgenic mice [30]. Consequently, it was concluded that
within our cells uncoupling did not take place through UCP1,
avUCP, UCP2 or UCP3.
3. Effect of UCP3 in the absence of uncoupling
The uncoupling activity of any UCP (UCP1, UCP2, UCP3 or
avUCP) could therefore not be observed in these CHO cell lines
because the appropriate activator was missing. However, it was
observed that the hyperpolarization due to oligomycin was
remarkably constant in the five different UCP3-expressing
clones (22 mV ±1), whereas it varied much more with the
controls (25 mV ±10) [1]. This suggested that, even in the
absence of an activator of the uncoupling activity, UCP3 could
influence mitochondrial activity. How could UCP3 guarantee
that hyperpolarization would be precisely controlled? Since
UCP3 is supposed to be a passive transporter in the
mitochondrial inner membrane of CHO cells, we proposed
that this hyperpolarization control was due to UCP3, which
ensures equilibration according to the Nernst law governing theconcentration of an ion between the mitochondrial matrix and
the cytosol. Accordingly, a variation of 22 mV would change by
a factor 2.4 the ratio between the external and internal
concentration of a monovalent ion. A hypothesis was
formulated [1], which should be divided into two separate
tenets: (1) UCP(3) acts as a uniporter controlling the distribution
of an ion relevant to mitochondrial metabolism, and (2) this ion
is pyruvate.
4. The uniport hypothesis
The first tenet is supported by the experimental evidence that
the hyperpolarization of mitochondria after oligomycin addition
in the UCP3 clones is constant (22 mV). It should be added that
this value was independent of UCP3 expression level in the
cellular clones. In relative terms the expression of UCP3 in
these clones varied from 1 to 10 (1 being a value close to the
physiological expression of UCP3 in muscle mitochondria
preparations). This tallies with the equilibration of an ion
through a specific transporter: the transporter needs to be
present, but its amount would simply make the equilibration
faster and would not influence the final state. This observation
is a supplementary argument against a “cryptic” uncoupling
activity that would have escaped other investigations, because,
in the case of uncoupling, UCP abundance would matter.
UCPs belong to a large family of transporters of the
mitochondrial inner membrane [31]. Most of these transporters
are symporters such as the proton–phosphate symport or
exchangers such as the ATP/ADP translocase. In contrast, the
UCPs have been characterized as uniporters. It should be
recalled that cations are attracted inside negatively polarized
mitochondria whereas anions are driven out of the matrix. The
mitochondrial substrates are organic anions, and it therefore
Fig. 4. Relationship between respiratory rate (y axis) and membrane potential (x
axis) in yeast mitochondria in state 4: Respiratory rate is expressed in nmol O2/
minute/mg of protein and membrane potential in millivolts. A constant
stoichiometry between proton pumping and oxygen consumption is supposed,
hence the y axis is proportional to the conductance of the inner membrane for
protons. Starting from state 4 (top value), decreasing respiration values were
generated by adding increasing amounts of cyanide. Empty symbols: in the
absence of nigericin. Filled symbol: in the presence of nigericin. Top: control
mitochondria (yeast transformed with the empty vector). Middle: yeast
transformed with the avUCP expression vector. Bottom: zoom on the values
of state 4 rates, circles: control; squares: avUCP. The statistical significance of
the difference between the control value in the absence of nigericin and other
relevant values is indicated by *P=0.014 in both cases. Insets in top and middle
panels indicate the interpretation in terms of transport (see text).
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On the other hand, the existence of uniporters would lead to
accumulation of the cation or loss of the anion transported. The
history of UCPs supports the hypothesis of an anionic uniport.
In view of these considerations, we can re-examine some of
our data obtained with avUCP. This protein was studied using
the yeast expression system [2], where it gave results close to
those obtained before with mouse UCP2 [19]. For example,
retinoic acid addition to yeast mitochondria expressing avUCP
resulted in significant uncoupling [2]. In the absence of
retinoic acid, although the respiratory activity of avUCP
mitochondria remained higher than that of controls, no
evidence was found for an increased proton conductance in
these avUCP (Fig. 2 in [2]). In subsequent studies (Fig. 4), it
was observed that neither the state 4 rate of respiration nor the
proton conductance was affected after addition of the
potassium–proton exchanger nigericin to the avUCP mito-
chondria (Fig. 4, middle). In contrast, the same addition of
nigericin increased the state 4 rate of control mitochondria to a
value not different from that of avUCP (Fig. 4, bottom). In
other words “control +nigericin”= “avUCP”. It appeared
difficult at that time to propose a similar activity for UCP3
and nigericin. Nigericin addition was expected to convert any
remaining delta pH into delta psi (ΔΨ) and therefore we
anticipated an increase in membrane potential with little
change in respiratory rate. This did not happen, since only an
increase in respiratory rate was observed (Fig. 4). A slight
upward shift of the conductance curve (Fig. 4, top) suggests a
limited increase in proton conductance in the presence of
nigericin with control mitochondria. Therefore, the energy
stored in delta pH appeared to be lost when nigericin was
added. No such loss occurred in the presence of avUCP (Fig.
4, middle), probably because delta pH was already dissipated.
Possible interpretations are given in the insets of Fig. 4. In the
case of control mitochondria in the presence of nigericin, a
potassium conductance is proposed to explain the loss in delta
pH. With avUCP we propose the participation of a proton–
anion symport (via a normal yeast mitochondrial carrier?)
coupled to the anionic conductance of the avUCP. The anion
is unknown and must have been introduced by the
mitochondrial preparation. Both mechanisms (insets of Fig.
4) would dissipate delta pH without creating a delta psi
counterpart. In the absence of nigericin, the avUCP mitochon-
dria would differ from their control by a null delta pH. This
may explain the relative protection of these mitochondria
against oxidative stress [2] since it has been demonstrated that
delta pH promotes ROS production by mitochondria [32].
However, this delta pH-dependent ROS formation was shown
with mammalian complex I, something very different from the
situation found in yeast mitochondria.
The mechanisms proposed in the insets of Fig. 4 result in a
net proton transport, which would cause complete uncoupling
of mitochondria unless one of them, presumably the uniport, is
gated according to membrane potential and therefore occurs
with a significant amplitude only at high potential values. In the
absence of avUCP or nigericin (top of Fig. 4 empty circles), the
proton conductance is also somehow gated since it increasesabruptly above a certain potential. This is known as the non-
ohmic proton leak of the mitochondrial inner membrane. It is
noteworthy that the mechanisms proposed in the inset of Fig. 4
Fig. 5. The pyruvate hypothesis: A mitochondrion is depicted as a shaded box
within the cell (empty box), RC: respiratory chain. Pyruvate (CH3–CO–COO–)
is produced from glucose (glycolysis) when it enters the mitochondrion through
the pyruvate carrier (proton–pyruvate symport). Its fate is either to be oxidized
in the tricarboxylic cycle (TCA) or to be driven out of the mitochondrion by the
UCP3. Pyruvate can be converted into lactate in the cytosol. Compartmentaliza-
tion of pyruvate metabolism is shown by the horizontal black line dividing the
cytoplasmic compartment.
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the non-ohmic proton leak. Therefore, it is tempting to speculate
that this threshold is in fact a limit at which a suddenly
increasing number of mechanisms similar to those shown in the
insets can be recruited. This would reveal functional character-
istics shared by a number of components of the inner
membrane. The consequence is that there would be no unique
explanation for the non-ohmic proton leak, a phenomenon
thought to influence resting metabolic rate and energy
expenditure [33].
5. The pyruvate hypothesis
The second tenet is that the ion is pyruvate. This is a speculation
based on the assumption that a mitochondrial substrate is a good
candidate as a controlling ion and on the available literature, since it
has been shown that UCP1 is able to transport pyruvate [22,34].
Therefore, this activity is supposed to be themain function ofUCP3
in muscle. It is important to recognize here that till now there has
been no experimental evidence for this. Further arguments could be
put forward for the support of our hypothesis: (1) the greatest UCP3
expression has been shown in glycolytic fibres [35]; (2) in our
study, some of themodifications produced byUCP3 inCHOclones
disappearedwhen glucosewas removed from themedium [1]. Both
arguments strongly suggest a link between the presence of UCP3
and glycolysis. Accordingly, the pyruvate hypothesis would ensure
coexistence between intense glycolytic activity and mitochondria.
According to ourmodel, polarization ofmitochondriawould lead to
a decrease in the internal concentration of pyruvate since this
substrate is taken out by the anionic uniporter UCP3 in amembrane
potential-dependent manner. Therefore, mitochondria in glycolytic
cells would be equipped with a self-inhibiting mechanism that
removes mitochondrial substrate as polarization increases and
would moderate the Pasteur effect by which mitochondria inhibit
glycolysis. Moreover, reduction of components of the respiratory
chain, hence ROS formation (see above), is controlled by substrate
availability and membrane potential. By linking these two
parameters UCP3 would control ROS formation without any
energywaste.While our data are consistent with this proposal when
cells are observed in their basal state, this was no longer the case in
the presence of oligomycin (Fig. 3) and [1]. In the presence of
oligomycin, the respiratory rate, and therefore also the substrate
utilization rate, is three to four times lower, consequently it may be
expected that the decrease in internal substrate concentration caused
by UCP has fewer/no consequences.
The association between the pyruvate carrier and the UCP
uniport (Fig. 5) results in the net transport of protons, and hence
uncoupling [34]. A similar mechanism was proposed years ago
to explain the uncoupling activity of the UCP [10] and also of
other mitochondrial carriers by a fatty acid cycling mechanism
[36]. In this model, the protonated form of the fatty acid does
not need a specific carrier since it can diffuse through
phospholipids. As we said before, models were proposed in
which new UCPs remove fatty acids from the mitochondrial
matrix [26–28]. A major difficulty is the hydrophobic nature of
fatty acids and, in fact, in these models the activity of the UCP
does not differ from that explaining the uncoupling activity ofthe UCP in the fatty acid cycling model. This problem does not
arise with a hydrophilic molecule like pyruvate. However,
gating (see above) or compartmentalization of pyruvate
metabolism (as suggested in Fig. 5) would prevent the
uncoupling cycle from occurring. While association of
hexokinase (the first enzyme of the glycolytic pathway) with
mitochondria has been known for many years [37], it was
shown recently that a complete glycolytic pathway is co-
purified with plant mitochondria, and this led to the proposal
that there is a local delivery of pyruvate to mitochondria [38].
So, there is a real possibility of compartmentalization of
pyruvate metabolism.
It was remarked during the meeting that pyruvate is a leaky
substrate during reconstitution experiments and therefore attribu-
tion of the pyruvate transport activity to the UCP may be
questionable. The term leaky substrate means that the uncharged
protonated form of this organic acid is able to cross the
phospholipid bilayer. This deserves two comments: (1) the surface
ratio between phospholipids and proteins is very different in
liposomes and mitochondria; (2) this remark should also be
addressed to the pyruvate carrier, since its activity (Fig. 5) matches
precisely the permeation processmentioned above. In this respect, it
should be pointed out that on the one hand the pyruvate carrier is
supposed to be present in all mitochondria, and on the other hand
the molecular identification of the protein remains elusive.
6. Glutamine and UCP2
The role of the new UCPs in mitochondrial metabolism
remains unclear. The study of factors controlling the expression
Fig. 7. Substrate control by the UCP and nucleotide inhibition: A mitochondrion
is depicted as a grey box. Substrate (S−) entry occurs via a transporter (empty
circle). Top: The substrate is used by the OXPHOS system to supply ATP to the
cytosol. This ATP keeps the UCP inhibited (black shape). Bottom: The
OXPHOS system is impaired and mitochondrial ATP production declines,
which lowers the ATP concentration and AMP is unable to inhibit the UCP
(white shape). Then the substrate uniport out of the mitochondrion is possible
with greater amplitude as soon as a potential is generated. Substrate retention in
mitochondria is limited to the amount necessary to reach a potential where entry
and exit+consumption of substrate are equivalent.
Fig. 6. Translation of UCP2. (A) The 5′ region of the UCP2 mRNA is shown,
the non-coding sequences are shown as a black line, open reading frame is
shown as boxes. AUG methionine initiating codons are indicated, three inframe
AUG codons are present in the uORF preceding the UCP2 coding sequence, so
the AUG codon initiating UCP2 translation is the fourth. (B) Translation of
UCP2 is impaired by uORF, and ribosomal subunits start scanning the mRNA at
its 5′ end. When they encounter the AUG of the uORF, translation is initiated
and the large ribosomal subunit joins the complex to start translation of the
uORF. The 36-amino-acid peptide coded by uORF (pp36) has not been detected
yet. Ribosomal subunits dissociate at the end of the uORF. UCP2 translation is
possible with a low efficiency (dotted lines) as few ribosomal subunits ignore the
AUGs of uORF (leaky scanning). (C) When glutamine reaches concentrations
around 1 mM, the induction of UCP2 translation is maximal. The presence of the
uORF no longer inhibits UCP2 translation. This is explained by a reinitiation
process according to which small ribosomal subunits do not dissociate at the end
of the uORF but resume scanning to reach the UCP2 AUG initiating codon. This
is a simplified view and some reinitiation may occur in situation B.
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and a relevant hypothesis about the transport(s) involved might
then be formulated and validated. In this respect, it should be
recalled that the relevance of UCP1 expression to cold
adaptation was established before its transport activity was
known [39]. Our studies in several models have shown that
UCP2 expression can be controlled exclusively at the level of
translation: while mRNA levels did not change, protein levels
increased in animals after various stimuli [40]. These stimuli
shared the common property of increasing oxidative stress.
Therefore, UCP2 appeared as a protein whose expression can be
quickly induced by the mobilization of an existing mRNA pool
whose translation is stimulated.
We observed that increasing the glutamine concentration in
the culture medium stimulated UCP2 mRNA translation in
several cell lines representing relevant sites of UCP2 expres-
sion: macrophages, pancreatic beta cells, colonocytes [4]. It
should be recalled that macrophage activity and insulin
secretion were altered in UCP2-knockout mice. Glutamine is
known to be a substrate for the immune system and the gutepithelium, two sites of UCP2 expression. Induction occurs at
physiological concentrations of glutamine (around 1 mM). In
contrast, our attempts to promote UCP2 expression by in-
creasing oxidative stress in cell cultures have failed.
The mechanism underlying regulation of UCP2 translation
by glutamine has been deciphered [4]: the translation of UCP2
from the UCP2 mRNA is normally inhibited because of the
existence of an upstream open reading frame (uORF) in the long
5′ untranslated region of the UCP2 mRNA [3,40]. When
stimulation of UCP2 translation occurs, the inhibitory effect of
this uORF is lost (Fig. 6).
This raises the question of a link between UCP2 and the
mitochondrial utilization of glutamine as a substrate. It is
unlikely that UCP2 is the mitochondrial glutamine transporter
since the latter was purified from kidney mitochondria and has a
different molecular weight from UCP2 [41]. Moreover, UCP2
was undetectable in kidney mitochondria [40,42]. Ongoing
studies are comparing intracellular glutamine metabolism in
wild-type and UCP2-knockout animals.
7. Concluding remarks
Studies using recombinant expression of UCPs have well
documented the proton transport activity of UCP2, UCP3, and
avUCP. However, there are still unresolved issues concerning
Fig. 8. UCP2, UCP3 and metabolism: Top: classical mitochondrial pyruvate
enters the tricarboxylic (Krebs) cycle (TCA). Bottom: UCP expression is
relevant to situations where pyruvate is mainly directed to formation of lactate
(UCP3) or when TCA is not fed by pyruvate but by glutamine (UCP2).
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UCPs regulated in the same manner? What are the regulators?
Which ones are physiologically relevant? Finally, is the
transport of other ions of more physiological relevance than
proton transport in the case of the new UCPs?
There is ample evidence that UCP2, and to a lesser extent
UCP3, plays a role in the control of oxygen radicals in vivo, but
this evidence is rarely associated with a clear demonstration of
respiration uncoupling. It is likely that while uncoupling may
occur in some models, its detection would be difficult. But does
uncoupling explain all the effects of the UCPs reported so far?
For example, data recorded in vivo show that the health of mice
is worsened or improves according to the level of UCP2
expression [43,44]. Whatever the mechanism involved, UCP2
is a negative modulator of macrophage activity [14]. When
lesions are examined in mouse models, it is difficult to
distinguish the direct and indirect damage due to the “cleaning”
activity of macrophages. In other words, what has been
attributed to the protective effect of UCP2, in preventing ROS
formation within one cell, might also have been attributed to a
moderation of macrophage activity around this cell.
In studies with yeast mitochondria, we have demonstrated a
yeast uncoupling pathway (YUP) [45], which appears to work
as a safety valve. Uncoupling by YUP is activated by ATP, and
inhibited by ADP and phosphate [46]. Therefore, when
mitochondria approach state 4 because all the cellular ADP
had been phosphorylated into ATP, YUP uncoupling activity is
triggered. In contrast, UCPs are all thought to be inhibited by
the binding of the nucleotides (ATP, ADP, GTP, GDP) initially
shown to be inhibitors of UCP1 activity. In this respect, UCPs
seem poorly adapted to work as a safety valve similar to YUP. It
appears easier to reconcile nucleotide inhibition with the
anionic conductance proposed here (Fig. 7). If mitochondriacontribute efficiently to ATP production, then the UCP is
inhibited. Inhibition in fact means raising of the threshold at
which conductance occurs, and so substrates remain within the
mitochondria (Fig. 7, top). Conversely, if mitochondria cease to
provide ATP then the drop in ATP lowers the threshold at which
the loss of substrate occurs. The worst case scenario is shown
with AMP, which does not inhibit UCP (Fig. 7, bottom).
As a final remark we would like to stress that the expression
of UCP3 in glycolytic fibres and the induction of UCP2 by
glutamine point to situations where the fate of pyruvate is not to
enter the tricarboxylic cycle (Fig. 8). This is well in line with the
proposed hypothesis.
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